The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable buzz within the medical community. This groundbreaking dual GIP and GLP-1 agonist medication appears to deliver notable improvements in fat shedding compared to existing therapies. Initial clinical studies have shown